StockWatch
·
Pharmaceuticals
Board Meeting26 Oct 2026, 01:51 pm

Amanta Healthcare Board Meeting on Nov 3 to Consider Q2 FY27 Results

AI Summary

Amanta Healthcare Limited has announced that its Board of Directors will convene on Tuesday, November 3, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. Additionally, the company has informed that the trading window, which was closed from October 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, will reopen on Friday, November 6, 2026.

Key Highlights

  • Board meeting scheduled for November 3, 2026.
  • To consider and approve Unaudited Financial Results for Q2 FY27.
  • Trading window to reopen on November 6, 2026.
  • Compliance with SEBI Insider Trading Regulations noted.